Invasive aspergillosis in a paediatric haematology department: A 15-year review

Mycoses

Volumn 51, Issue 2, 2008, Pages 109-116

  Crassard, Nicolas ^a,d   Hadden, Hélène ^a   Piens, Marie Antoinette ^b   Pondarré, Corinne ^a   Hadden, Richard ^c   Galambrun, Claire ^a   Pracros, Jean Pierre ^a   Souillet, Gérard ^a   Basset, Thierry ^a   Berthier, Jean Claude ^a   Philippe, Noel ^a   Bertrand, Yves ^a  

^a HÔPITAL DEBROUSSE   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITY OF SOUTHERN MISSISSIPPI   (United States)

^d Centre Hospitalier Fleyriat   (France)

Author keywords

Cancer; Children; Haematology; Invasive aspergillosis; Lung

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CORTICOSTEROID; FLUCYTOSINE; GAMMA INTERFERON; ITRACONAZOLE; MICONAZOLE; VORICONAZOLE;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ASPERGILLOSIS; CHILD; CLINICAL ARTICLE; FEMALE; HEMOPTYSIS; HUMAN; KIDNEY DYSFUNCTION; LEUKEMIA RELAPSE; LUNG DISEASE; LUNG LAVAGE; MALE; MEDICAL RECORD REVIEW; MORTALITY; NEUTROPENIA; OUTCOME ASSESSMENT; PEDIATRIC WARD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; THORAX SURGERY; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

ADOLESCENT; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOLOGY; HOSPITAL DEPARTMENTS; HUMANS; INCIDENCE; INFANT; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; LUNG DISEASES, FUNGAL; MALE; PEDIATRICS; PROGNOSIS; TREATMENT OUTCOME;

EID: 38849172579     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2007.01449.x     Document Type: Review

References (28)

1. Rankin N. Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy. Br Med J 1953 1: 918 19.
2. Wiley JM, Seibel NL, Walsh TJ. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections. Pediatr Infect Dis J 2005 24: 167 74.
3. Rosen GP, Nielsen K, Glenn S, Abelson J, Deville J, Moore TB. Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution. J Pediatr Hematol Oncol 2005 27: 135 40.
4. Fraser DW, Ward JI, Ajello L, Plikaytis BD. Aspergillosis and other systemic mycoses. The growing problem. JAMA 1979 242: 1631 5.
5. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996 33: 23 32.
6. Mc Neil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA. Trends in the mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001 33: 641 7.
7. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases [published erratum appears in Rev Infect Dis 1991; 13: 345]. Rev Infect Dis 1990 12:1147 201.
8. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002 34:7 14.
9. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984 100:345 51.
10. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998 26:781 803.
11. Weinberger M, Elattar I, Marshall D et al. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore) 1992 71:24 43.
12. Abbasi S, Shenep JL, Hughes WT, Flynn PM. Aspergillosis in children with cancer: a 34-year experience. Clin Infect Dis 1999 29:1210 19.
13. Walmsley S, Devi S, King S, Schneider R, Richardson S, Ford-Jones L. Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J 1993 12:673 82.
14. Pagano L, Ricci P, Nosari A et al. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell'Adulto). Br J Haematol 1995 89:500 5.
15. Albelda SM, Talbot GH, Gerson SL, Miller WT, Cassileth PA. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia. Am Rev Respir Dis 1985 131:115 20.
16. Caillot D, Casasnovas O, Bernard A et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997 15:139 47.
17. Blum U, Windfuhr M, Buitrago-Tellez C, Sigmund G, Herbst EW, Langer M. Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest 1994 106:1156 61.
18. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 1992 86:243 8.
19. Stevens DA, Kan VL, Judson MA et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000 30:696 709.
20. Walsh TJ, Lutsar I, Driscoll T et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 2002 21:240 8.
21. Cesaro S, Strugo L, Alaggio R et al. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience. Support Care Cancer 2003 11:722 7.
22. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002 347:408 15.
23. Girmenia C, Martino P. New antifungal drugs and new clinical trials: interpreting results may be difficult. Curr Opin Oncol 2003 15:283 8.
24. Gow KW, Hayes-Jordan AA, Billups CA et al. Benefit of surgical resection of invasive pulmonary aspergillosis in pediatric patients undergoing treatment for malignancies and immunodeficiency syndromes. J Pediatr Surg 2003 38:1354 60.
25. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001 32:358 66.
26. Zaoutis TE, Heydon K, Chu JH, Walsh TJ, Steinbach WJ. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 2006 117:711 16.
27. Groll AH, Kurz M, Schneider W et al. Five-year-survey of invasive aspergillosis in a pediatric cancer centre. Epidemiology, management and long-term survival. Mycoses 1999 42:431 42.
28. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996 23:608 15.